An act relating to health insurance coverage for biomarker testing

The bill requires health insurance plans in Vermont to cover biomarker testing, which helps in identifying specific characteristics of diseases, particularly cancer. This testing can guide treatment decisions and improve patient outcomes. By mandating coverage, the bill aims to make these essential tests more accessible to patients.

Supporters of the bill argue that it is a crucial step towards personalized medicine, allowing patients to receive targeted treatments based on their unique health profiles. They believe that covering biomarker testing will lead to better health outcomes and potentially lower overall healthcare costs by ensuring patients receive the most effective treatments sooner.

Critics of the bill may argue that mandating coverage for biomarker testing could increase insurance premiums for all policyholders. They might express concerns about the costs associated with implementing such requirements and question the necessity of widespread coverage for tests that may not be applicable to all patients.